The total number of records retrieved from this search are 5. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_849	Virus nameHerpes simplex virus	Virus strainHSV-G207	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDeletion mutant in ICP34.5 and ICPC6 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineEpithelial ovarian carcinoma	Cell lineA2784	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityMinimal cytotoxic to mesothelial cells	AssayBeta galacosidase colorimetric proliferation assay	In-vitro virus concentration0.1 MOI	In-vitro result75% cancer cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID10770637
IDOV_850	Virus nameHerpes simplex virus	Virus strainHSV-G207	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDeletion mutant in ICP34.5 and ICPC6 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineEpithelial ovarian carcinoma	Cell lineA2784	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityMinimal cytotoxic to mesothelial cells	AssayBeta galacosidase colorimetric proliferation assay	In-vitro virus concentration1 MOI	In-vitro result98% cancer cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID10770637
IDOV_851	Virus nameHerpes simplex virus	Virus strainHSV-G207	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDeletion mutant in ICP34.5 and ICPC6 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineEpithelial ovarian carcinoma	Cell lineA2784	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityMinimal cytotoxic to mesothelial cells	AssayBeta galacosidase colorimetric proliferation assay	In-vitro virus concentration1 MOI	In-vitro result98% cancer cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID10770637
IDOV_852	Virus nameHerpes simplex virus	Virus strainHSV-G207	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDeletion mutant in ICP34.5 and ICPC6 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineEpithelial ovarian carcinoma	Cell lineA2784	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityMinimal cytotoxic to mesothelial cells	AssayBeta galacosidase colorimetric proliferation assay	In-vitro virus concentration1 MOI	In-vitro result98% cancer cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID10770637
IDOV_853	Virus nameHerpes simplex virus	Virus strainHSV-G207	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationDeletion mutant in ICP34.5 and ICPC6 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineEpithelial ovarian carcinoma	Cell lineA2784	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityMinimal cytotoxic to mesothelial cells	AssayBeta galacosidase colorimetric proliferation assay	In-vitro virus concentration1 MOI	In-vitro result98% cancer cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID10770637